Fibroblast growth factor 2 conjugated superparamagnetic iron oxide nanoparticles (FGF2-SPIONs) ameliorate hepatic stellate cells activation in vitro and acute liver injury in vivo

Fibroblast Growth Factor 9 is expressed by activated hepatic stellate cells and promotes progression of hepatocellular carcinoma

(2020) Tatjana Seitz et al.   Scientific Reports

Fibroblast Growth Factor 2 Attenuates Renal Ischemia-Reperfusion Injury via Inhibition of Endoplasmic Reticulum Stress

(2020) Xiaohua Tan et al.   Frontiers in Cell and Developmental Biology

Engineered Relaxin as Theranostic nanomedicine to diagnose and ameliorate liver cirrhosis

(2019) Beata Nagórniewicz et al.   Nanomedicine-Nanotechnology Biology and Medicine

Fibroblast growth factor 2 decreases bleomycin-induced pulmonary fibrosis and inhibits fibroblast collagen production and myofibroblast differentiation

(2018) Hyun Young Koo et al.   JOURNAL OF PATHOLOGY

Burden of Liver Diseases in the World

(2018) Sumeet K. Asrani et al.   JOURNAL OF HEPATOLOGY

Nano-targeted relaxin impairs fibrosis and tumor growth in pancreatic cancer and improves the efficacy of gemcitabine in vivo

(2018) Deby F. Mardhian et al.   JOURNAL OF CONTROLLED RELEASE

Fibroblast growth factor 2 (FGF2) regulates cytoglobin expression and activation of human hepatic stellate cells via JNK signaling

(2017) Misako Sato-Matsubara et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

FGF2 regulates proliferation, migration, and invasion of ECA109 cells through PI3K/Akt signalling pathway in vitro

(2016) Hui Shi et al.   CELL BIOLOGY INTERNATIONAL

Clinical Advancements in the Targeted Therapies against Liver Fibrosis

(2016) Ruchi Bansal et al.   MEDIATORS OF INFLAMMATION

Regulation of Hepatic Stellate Cells and Fibrogenesis by Fibroblast Growth Factors

(2016) Justin D. Schumacher et al.   Biomed Research International

Magnetic nanoparticle-based drug delivery for cancer therapy

(2015) Rainer Tietze et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Low-molecular-weight fibroblast growth factor 2 attenuates hepatic fibrosis by epigenetic down-regulation of Delta-like1

(2015) Ruo-Lang Pan et al.   HEPATOLOGY

The Fibroblast Growth Factor signaling pathway

(2015) David M. Ornitz et al.   Wiley Interdisciplinary Reviews-Developmental Biology

Evolving therapies for liver fibrosis

(2013) Detlef Schuppan et al.   JOURNAL OF CLINICAL INVESTIGATION

HS-173, a Novel PI3K Inhibitor, Attenuates the Activation of Hepatic Stellate Cells in Liver Fibrosis

(2013) Mi Kwon Son et al.   Scientific Reports

Fibroblast growth factor (Fgf) signaling pathway regulates liver homeostasis in zebrafish

(2012) Su-Mei Tsai et al.   TRANSGENIC RESEARCH

Dextran-Coated Iron Oxide Nanoparticles: A Versatile Platform for Targeted Molecular Imaging, Molecular Diagnostics, and Therapy

(2011) Carlos Tassa et al.   ACCOUNTS OF CHEMICAL RESEARCH

Iron oxide nanoparticles for targeted cancer imaging and diagnostics

(2011) Joshua E. Rosen et al.   Nanomedicine-Nanotechnology Biology and Medicine

Delivery of Therapeutic Proteins

(2010) Dipak S. Pisal et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Fibroblast Growth Factors: Biology, Function, and Application for Tissue Regeneration

(2010) Ye-Rang Yun et al.   Journal of Tissue Engineering

Mechanisms of Hepatic Fibrogenesis

(2008) Scott L. Friedman   GASTROENTEROLOGY

Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver

(2008) Scott L. Friedman   PHYSIOLOGICAL REVIEWS